Beschreibung
Summary of butyrate supplementation outcomes in IBD patients encompassing circadian-clock gene regulation, sleep quality improvement, and inflammation reduction. The findings support short-chain fatty acids as potential adjunct therapy.
Figure 6
Source Paper
Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative …Cite This Figure
![Figure 6: Summary of butyrate supplementation outcomes in IBD patients encompassing circadian-clock gene regulation, sleep quality improvement, and inflammation reduction. The findings support short-chain fatty acids as potential adjunct therapy.]() > Source: Donya Firoozi et al. "Effects of short-chain fatty acid-butyrate supplementation on expression of circ." *Lipids in health and disease*, 2024. PMID: [39003477](https://pubmed.ncbi.nlm.nih.gov/39003477/)
<figure> <img src="" alt="Summary of butyrate supplementation outcomes in IBD patients encompassing circadian-clock gene regulation, sleep quality improvement, and inflammation reduction. The findings support short-chain fatty acids as potential adjunct therapy." /> <figcaption>Figure 6. Summary of butyrate supplementation outcomes in IBD patients encompassing circadian-clock gene regulation, sleep quality improvement, and inflammation reduction. The findings support short-chain fatty acids as potential adjunct therapy.<br> Source: Donya Firoozi et al. "Effects of short-chain fatty acid-butyrate supplementation on expression of circ." <em>Lipids in health and disease</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39003477/">39003477</a></figcaption> </figure>